COLLPLANT BIOTECHNOLOGIES LTD
(NASDAQ: CLGN)

CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.

5.360

+0.130 (+2.49%)
Range 5.254 - 5.468   (4.07%)
Open -
Previous Close 5.230
Bid Price 7.410
Bid Volume 9
Ask Price 7.750
Ask Volume 8
Volume 2,648
Value -
Remark
Delayed prices. Updated at 29 Mar 2024 00:45.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 29 March 2024
View All Events


Loading Chart...

Please login to view stock data and analysis